The BioVentures Institute is an innovation-driven molecular biotechnology company, conducting applied research, product development and production, utilizing advanced genetic engineering, molecular biology, biochemical and microbiological technologies.
BioVentures Institute developed DNA-FACE™ (DNA Fragment Amplification & Concatemeric Expressed Nucleic Acids and Proteins) technology. DNA-FACE™ is a universal biotechnological platform, created with the use of genetic engineering methods, based on directional, ordered amplification of natural or designed DNA fragments, coding for a specific function. This isothermal enzymatic reaction leads to the construction of targeted, concatemeric biological macromolecules, including DNA, RNA, proteins. DNA-FACE™ is applicable to the development of new generation, protein- or mRNA-based vaccines, genetically programmed DNA, RNA, mRNA, proteins and biological drugs, as well as to industrial and environmental processes.
Company Details
- Employees
- 2
- Founded
- -
- Address
- Promienista, 83,poland
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.bvi.com.pl
- Keywords
- IBCH.
- HQ
- Poznań, Woj. Wielkopolskie
Bioventures Institute Questions
Bioventures Institute's website is http://www.bvi.com.pl
Bioventures Institute's LinkedIn profile is https://pl.linkedin.com/company/bioventures-institute
Bioventures Institute has
2 employees.
View email and phone details for 2
employees at Bioventures Institute.
Bioventures Institute's industry is
Biotechnology Research
Bioventures Institute's top competitors are
Labostat,
Cellivia,
Synevo Poland,
Zwiers Regulatory Consultancy – A Productlife Group Company,
Ibch,
Imol,
Ocean Network Express,
Genomed,
Fileclo.
Bioventures Institute's categories are Biotechnology Research
Bioventures Institute's founding year is 2012
